share_log

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC韦恩赖特重新买入biocardia,维持25美元的目标价
Benzinga ·  08/21 13:32  · 评级/大行评级

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

HC韦恩赖特分析师Joseph Pantginis重申买入biocardia (纳斯达克:BCDA),并维持目标价25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发